嗜铬细胞瘤诊疗的研究进展
Research advances in diagnosis and treatment of pheochromocytoma
吴小荣 1陈勇辉1
作者信息
- 1. 上海交通大学医学院附属仁济医院泌尿科,上海 200127
- 折叠
摘要
嗜铬细胞瘤(pheochromocytoma,PHEO)是较少见的神经内分泌肿瘤.2022年WHO对PHEO/副神经节瘤(paranganglioma,PGL)作出了新的定义,并介绍了治疗进展.本文对PHEO分型、诊断、治疗及临床预后等方面的最新研究结果进行汇总,以指导临床医师进行相应的诊疗,改善预后.
Abstract
Pheochromocytoma(PHEO)is a rare neuroendocrine tumor.In 2022,WHO made the new definition of PHEO/paranganglioma(PGL)and introduced the progress of treatment.This paper summarizes the classification,diagnosis,treatment,clinical prognosis of PHEO and the new research results so as to guide clinicians to carry out relative diagnosis and treatment and improve the prognosis of the patients.
关键词
嗜铬细胞瘤/副神经节瘤/诊断/治疗Key words
pheochromocytoma/paranganglioma/diagnosis/treatment引用本文复制引用
出版年
2024
NETL
NSTL
万方数据